The US Food and Drug Administration (FDA) has granted approval for Alpha Tau Medical’s investigational device exemption (IDE) application to initiate a study of its Alpha diffusing alpha ...

UCB (OTCPK:UCBJY) (OTCPK:UCBJF) said it has received FDA approval for its drug Bimzelx for the treatment of active psoriatic arthritis, active ankylosing spondylitis, and non-radiographic axial ...

Prescription drugs such as Ozempic, WeGovy, and Mounjaro have gained popularity as game changers due to their ability to ...

The U.S. Food and Drug Administration has granted approval to the first new schizophrenia drug type in decades. The new drug, Cobenfy, is marketed by pharmaceutical giant Bristol Myers Squibb.

On Thursday, the Food and Drug Administration approved for the first time a new type of medicine that may change the way the psychiatric disorder is treated. The drug, called Cobenfy ...

Sept 24(Reuters) - The U.S. Food and Drug Administration approved IntraBio's drug for a rare and fatal genetic disorder, the health regulator said on Tuesday, just days after the agency cleared ...

The FDA approved IntraBio Inc.'s Aqneursa (levacetylleucine) yesterday for the treatment of ultra rare neurodegenerative disease Niemann-Pick Disease, Type C (NPC), according to a news release. This ...

Geron’s imetelstat (Rytelo) received FDA approval for MDS ... a lipid conjugated 13-nucleotide nucleic acid fragment that targets the RNA template of telomerase. Telomere is a short, protective ...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...